HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MHY966

structure in first source

Also Known As:

2-bromo-4-(5-chloro-benzo(d)thiazol-2-yl)phenol

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        MHY966: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - Benzothiazoles: 40
        MHY966: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzothiazoles: 40
      - MHY966: 1

Experts

1.	Choi, Yeon Ja: 1 article (12/2012)
2.	Chun, Pusoon: 1 article (12/2012)
3.	Chung, Hae Young: 1 article (12/2012)
4.	Chung, Ki Wung: 1 article (12/2012)
5.	Ha, Young Mi: 1 article (12/2012)
6.	Kim, Ji Min: 1 article (12/2012)
7.	Moon, Hyung Ryong: 1 article (12/2012)
8.	Park, Ji Young: 1 article (12/2012)
9.	Park, June Whan: 1 article (12/2012)
10.	Song, Yu Min: 1 article (12/2012)

Related Diseases

1.	Hypopigmentation (Hypomelanosis) 12/01/2012 - "This hypopigmentation effect induced by MHY966 treatment was mediated by the down-regulation of tyrosinase, PKG, and nuclear MITF, which was accompanied by decreased NO and NO-related oxidative stress. "
2.	Melanoma (Melanoma, Malignant) 12/01/2012 - "NO generation, melanin synthesis, and the expression of tyrosinase and PKG were measured in B16F10 melanoma cells to verify the anti-melanogenic effect of MHY966 in vitro. "

Related Drugs and Biologics

1.	Monophenol Monooxygenase (Tyrosinase)
2.	Melanins (Melanin)